Catatan sumber primer
primary_outcomes: ['Adverse Events (AEs), Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)'] → ['Jumlah Peserta yang Mengalami Treatment-Emergent Adverse Events (TEAEs)']
DBV Technologies menunda pengajuan BLA VIASKIN Peanut ke Q3 2026
DBV Technologies menyajikan data subgrup VITESSE dan protokol THRIVE di EAACI 2026